Skip to content

The Efficacy and Safety of Hyaluronic Acid Filler on the Treatment of Horizontal Neck Lines

The Efficacy and Safety of Hyaluronic Acid Filler on the Treatment of Horizontal Neck Lines

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220214003
Enrollment
30
Registered
2022-02-14
Start date
2018-02-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with moderate horizontal neck lines based on the Horizontal Neck Wrinkle Severity Scale neck lines, HA filler, hyaluronic acid

Interventions

Topical anesthetic cream with 2.5% lidocaine and 2.5% prilocaine (EMLA, AstraZeneca AB, Sweden) was applied to the area of treatment for 40 minutes before the procedure. After topical anesthetic cream
Experimental Drug
HA filler (Belotero Balance)

Sponsors

The Dhurakij Pundit University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 39 Years

Inclusion criteria

Inclusion criteria: 1. aged 30-39 years 2. patients with moderate horizontal neck lines based on the Horizontal Neck Wrinkle Severity Scale

Exclusion criteria

Exclusion criteria: 1. previous history of hypersensitivity reactions to HA filler 2. patients who have undergone ablative or semi-ablative laser, or energy-based device procedures on the neck within the past 6 months, history of botulinum toxin, filler, or mesotherapy on the neck region within the past year, or patients who have undergone surgical neck lift.

Design outcomes

Primary

MeasureTime frame
Physician improvement baseline, immediately post-procedure, and at 2 weeks, 1 month, 3 months and 6 months after the treatment. quartile grading scale

Secondary

MeasureTime frame
Patient improvement baseline, immediately post-procedure, and at 2 weeks, 1 month, 3 months and 6 months after the treatment. quartile grading scale,Patient satisfaction 2 weeks, 3 months, and 6 months after treatment percent improvement,Safety immediately post-procedure, and at 2 weeks, 1 month, 3 months and 6 months after the treatment. Adverse event

Countries

Thailand

Contacts

Public ContactRungsima Wanitphakdeedecha

Faculty of Medicine Siriraj Hospital, Mahidol University

rungsima.wan@mahidol.ac.th66816406300

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026